Dr Raymond W Smith, MD | |
1301 E Lincoln Rd, Idabel, OK 74745-7300 | |
(580) 208-3159 | |
Not Available |
Full Name | Dr Raymond W Smith |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1301 E Lincoln Rd, Idabel, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194727685 | NPI | - | NPPES |
100165840B | Medicaid | KS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 424834 (Kansas) | Secondary |
2085R0202X | Radiology - Diagnostic Radiology | 24208 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Raymond W Smith, MD 1301 E Lincoln Rd, Idabel, OK 74745-7300 Ph: (580) 208-3159 | Dr Raymond W Smith, MD 1301 E Lincoln Rd, Idabel, OK 74745-7300 Ph: (580) 208-3159 |
News Archive
According to results released today from the newest survey of people with Crohn's disease, "Voices of Crohn's," 60 percent of people with Crohn's, between the ages of 18 and 34, have been hospitalized within the last two years and more than half have required surgery within the past five years.
Methicillin-resistant Staphylococcus aureus (MRSA), a type of staph bacteria that does not respond to commonly used antibiotic treatments, is a type of infection that has been a problem in hospital settings for many years. Back in 2000 it began steadily making its way into the lives of otherwise healthy people, especially children, who are not typically at risk for the fast-moving bacteria.
Nanoparticles can function as carriers for medicines to combat lung cancer: Working in a joint project at the NIM (Nanosystems Initiative Munich) Excellence Cluster, scientists from the Helmholtz Zentrum München and the Ludwig-Maximilians-Universität in Munich have developed nanocarriers that site-selectively release medicines/drugs at the tumor site in human and mouse lungs.
Patients admitted to a hospital with major trauma and treated with the steroid hydrocortisone were less likely to be diagnosed with hospital-acquired pneumonia than patients who received placebo, according to a study in the March 23/30 issue of JAMA.
As the COVID-19 pandemic rages in many parts of the world, a new study shows that smoking may not play a significant role in increasing the severity of illness in these patients. The study is published on the preprint server medRxiv* in May 2020.
› Verified 9 days ago